Jilin Hengde Investment Information Consulting Co., Ltd. agreed to acquire Jilin Zixin Dunhua Medicine & Herbs Co., Ltd. from Jilin Zixin Pharmaceutical Industrial Co.,Ltd. (SZSE:002118) for CNY 1 million on August 27, 2020. Jilin Zixin Dunhua Medicine & Herbs generates total assets of CNY 229.6 million, net assets of CNY -25.9 million, revenue of CNY 85.8 million and net profit of CNY -18.8 million. The Board of Directors of Jilin Zixin Pharmaceutical Industrial approved the transaction and does not need the Shareholders’ approval.